The Efficacy of Selective Laser Trabeculoplasty

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2006 by Glaucoma Research & Education Group.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
PharmaLogic Development, Inc.
Information provided by:
Glaucoma Research & Education Group
ClinicalTrials.gov Identifier:
NCT00347893
First received: June 30, 2006
Last updated: NA
Last verified: June 2006
History: No changes posted

June 30, 2006
June 30, 2006
May 2006
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
The Efficacy of Selective Laser Trabeculoplasty
Clinical Results of Selective Laser Trabeculoplasty in Treatment of Open Angle Glaucoma

Selective laser trabeculoplasty (SLT) is a new method to reduce intraocular pressure in eyes with open angle glaucoma or ocular hypertension. SLT may also be effective for cases with previously failed ALT procedures. We will study the efficacy and safety of the SLT procedure.

Selective laser trabeculoplasty (SLT) has been shown to be a safe, well tolerated, and effective intraocular pressure reduction therapy for several forms of open-angle glaucoma. SLT produces significantly less disturbance to the trabecular meshwork and is theoretically more repeatable than the ALT procedure. This retrospective research will begin with cases treated in 2001. It will evaluate whether SLT is effective for patients who have had prior treatment with ALT and it will determine whether the IOP lowering effect is sustainable over time. It will also assess the efficacy of repeated SLT procedures.

Observational
Observational Model: Defined Population
Time Perspective: Longitudinal
Not Provided
Not Provided
Not Provided
Not Provided
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • Pseudo-Exfoliative Glaucoma
  • Pigment Dispersion Glaucoma
Procedure: Selective laser trabeculoplasty
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Patients with primary open angle glaucoma, ocular hypertension, pseudo exfoliative glaucoma, pigment dispersion glaucoma

Exclusion Criteria:

  • History of prior invasive glaucoma surgery
Both
Not Provided
Yes
Not Provided
United States
 
NCT00347893
22222
Not Provided
Not Provided
Glaucoma Research & Education Group
PharmaLogic Development, Inc.
Principal Investigator: Andrew G. Iwach, M.D. Glaucoma Research & Education Group
Glaucoma Research & Education Group
June 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP